Explore our new advisory brief for New Product Planning teams, featuring: 🟣 Guidance on when to incorporate commercial insights—from preclinical through post-launch 🟣 A framework for scaling input from early directional guidance to validated analysis 🟣 Examples of how timing and rigor shape product profiles, trial design, and payer strategy 🟣 Recommendations for building effective checkpoints and cross-functional collaboration See how optimizing commercial input can drive better outcomes across the development lifecycle: https://bit.ly/44buVQT
Trinity Life Sciences
Business Consulting and Services
Waltham, MA 122,995 followers
About us
With almost 30 years of expertise, a best-in-the-business team and unrivaled access to data and analytics, Trinity Life Sciences is a modern partner to companies in the life sciences industry. Trinity combines strategy, insights and analytics to help life science executives with clinical and commercial decision-making. We serve over 300 pharmaceutical, biotech and medical device clients, helping them develop the right drugs and devices for today’s market and optimize them once in market. In 2023, the company worked on 75% of all new drug launches and provides ongoing, in-depth, high value thought leadership that helps shape the industry. With a diverse staff of over 1,200 employees and 11 global offices across the U.S., Europe and Asia, Trinity continues to grow both organically and through acquisitions. These acquisitions included BluePrint Research Group, CBPartners, TGaS Advisors, Bell Canyon and D Cube Analytics, the latter of which dramatically leap-frogged Trinity to the leading provider of go-to-market analytics and AI to biopharma companies. Trinity has also entered into a transformative partnership with Bain & Company that has strategically advanced Trinity’s mission to revolutionize the pharmaceutical commercial model. Ultimately, we know that every decision our clients make impacts a life, and when we help our clients achieve their goals, the world benefits.
- Website
-
https://trinitylifesciences.com/
External link for Trinity Life Sciences
- Industry
- Business Consulting and Services
- Company size
- 1,001-5,000 employees
- Headquarters
- Waltham, MA
- Type
- Privately Held
- Founded
- 1996
- Specialties
- consulting, healthcare, lifesciences, strategy, valuation, primary market research, and advanced analytics
Locations
Employees at Trinity Life Sciences
Updates
-
As 2025 comes to a close, one question stands out: What's next for life sciences in 2026? Register now: https://bit.ly/3KoCP2M Join experts from Trinity, AstraZeneca, Tris Pharma, and Snowflake as they share bold predictions for 2026—and explore how Data and AI are reshaping commercial strategy today. In this fast-paced discussion, our panel will unpack how organizations are not just anticipating what’s ahead but actively shaping the future through smarter data, predictive insights, and AI-driven automation. We may not have a crystal ball, but our extensive work powering the future of life sciences commercialization with clients in data and AI and across the industry is revealing clear signals about where 2026 is headed. Featuring: Jonathan Jenkins | Shriram (Shri) Salem | Kaiwen Zhong | Jing Z. | Karthik Jayaraman | Jesse Cugliotta December 11, 2025 | 2:00–2:45 PM ET Additional sessions for EU & APAC
-
Four breakthroughs. One future for interventional cardiology. 📖 Read the full blog: https://bit.ly/4pCdiSJ Coming out of TCT 2025, the market is shifting toward precision-based care, where treatment strategies match patient characteristics and real-world outcomes guide decisions. At Trinity, we’re powering the future of life sciences commercialization by helping MedTech leaders turn insights into strategies that drive adoption and growth. Our latest blog highlights four trends shaping the next 2–3 years: ✅ Alternatives to DES gain traction with drug-coated balloons and resorbable scaffolds ✅ Calcium modification options expand beyond IVL ✅ LAAC and tMCS markets face real competition ✅ Renal denervation shows cautious optimism Trinity—Powering the future of life sciences commercialization
-
The Trinity Intelligence Newsletter – November 2025 Edition is here. Discover how we’re powering the future of life sciences commercialization. This month’s issue features: ⭐️ A panel discussion of AI predictions for 2026 💡 A white paper highlighting a better way forward for point-of-care (POC) measurement 🔍 An advisory brief examining the role of commercial insights across the drug development lifecycle 📱 The fifth annual Digital Marketing Competency Report ❗️ A blog examining trends reshaping interventional cardiology
-
We recently hosted an engaging session on the eight pillars of AI readiness for commercial life sciences organizations—powering the future of life sciences commercialization through smarter, more strategic adoption of AI. With insights from 40 companies, the discussion revealed both the opportunities and challenges of embracing AI in this space. Key takeaways from our live readiness assessment: 🔍 Many organizations are just beginning their AI journey, especially in areas like governance and understanding the investment value of AI. ✅ Use case maturity and change management are emerging as strengths, though most companies still consider themselves in the “developing” phase. 📊 Overall, 80% of participants rated their AI-readiness as “initial” or “early developing.” We’re excited to continue the conversation. If your team is exploring how to assess and accelerate AI-readiness, we’d love to connect and share how our tailored approach—grounded in stakeholder-specific insights—can help. Connect Today, Own Tomorrow. Reach out to learn more or start a dialogue: https://bit.ly/3KcGyjE Don’t miss our next webinar: Will AI Redefine Life Sciences? 2026 Predictions | Register here: https://lnkd.in/emYEe4vA Shriram (Shri) Salem, Kaiwen Zhong, Steven Laux
-
We’re excited to announce Scott Evangelista as Trinity’s new CEO. His unique experience—as a board advisor, global executive, and industry leader—makes him ideally suited to lead Trinity into its next chapter of growth, powering the future of life sciences commercialization. As Trinity welcomes Scott, we thank Leslie Orne for her decades of dedicated leadership and her continuing role as Senior Advisor and member of the board of directors. Read More: https://bit.ly/4oMmL9X
-
-
Trinity is honored to have been a sponsor for this year’s Sparkle of Hope Gala, joining industry leaders in supporting Community Hope's mission of providing hope and vital services for veterans, service members, and individuals facing mental health and housing challenges. The 2025 Gala was an inspiring evening held at The Legacy Castle in Pompton Plains, New Jersey. Thank you to everyone who made this very special event a success and helped bring Community Hope’s vital programs to more people in need. #SparkleOfHope #CommunityHope Dawn Mueller PhD, Herman Sanchez, Max Hunt, Yogesh Soneji, Kyle Martin, Kevin Chithran, Paul Harney, Christian Hoyvald, Carmine Deo, Brent Saunders, Will Lewis, Rob Davis, Olivier Bogillot, Bob Bradway, Victor Bultó, Adele Gulfo, Mark McKenna, Bill Meury, Joseph Papa, Tarek Rabah, Brent Ragans, Adam Schechter
-
-
-
-
-
+1
-
-
How confident are you in measuring the true impact of point-of-care marketing campaigns? We’re excited to share a new white paper developed with the Point of Care Marketing Association, Syneractiv, and MedFuse introducing the Patient Reach Index—a new metric combining provider coverage with real patient traffic to more accurately measure campaign performance. In our case study, this approach increased estimated campaign lift by 4.4x compared to traditional models. This collaboration shows how Trinity partners with industry leaders to combine domain expertise, real-world insights, and evidence-based AI, empowering life sciences organizations to uncover value, anticipate performance, and make smarter data-driven decisions across the enterprise. Download the white paper here: https://bit.ly/3Lu5SCh
The way we measure Point of Care media is changing fast. POCMA, Trinity Life Sciences, Syneractiv, and MedFuse have introduced the Patient Reach Index, a metric that captures both the number of offices reached and the number of patients who walk through each one. The result? A 4.4x Dive into how this new input redefines accuracy and accountability at the Point of Care. 📄 Read the full white paper: https://lnkd.in/eC7BYgqW Special thanks to: Adam McCutcheon, Joy J., and Kyle Ryder
-
Just Released: Trinity’s 5th Annual TGaS Digital Marketing Competency Report We’re proud to share the latest insights powering the future of life sciences commercialization — benchmarking digital maturity across 150+ biopharma brands. Key findings: 📈 19% more brands now rank as “Proficient” in digital strategy 📢 Reddit usage up 112% — as brands embrace community-driven channels 🧭 Direct-to-consumer models are gaining momentum 🏥 Genentech, GSK, Amgen, AstraZeneca, and AbbVie are leading in patient-focused digital innovation 📥 Download the summary: https://bit.ly/4oVyeUh 📅 Book a 30-min consult with our Omnichannel team: https://lnkd.in/egBgKNBA
-
We’re proud to be recognized in Vault’s 2026 Internship Rankings as a Top Program for Life Sciences! Thank you to our interns for sharing their experiences and making this recognition possible. Through Vault, we’re able to connect with hundreds of thousands of students and early talent professionals, continuing to grow our impact and reach. This recognition reflects the heart of our culture: bold minds that challenge, smart tech that connects, and a committed partner that delivers—values that shape every experience we create.